Safety, tolerability, and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine in healthy adults: an open-label randomized phase I clinical trial
Authors:
- Renan James LimRLRenan James Lim
- Xiangyan QiuXQXiangyan Qiu
- Robert Neil LeongRLRobert Neil Leong
- Jose Limuel GutierrezJGJose Limuel Gutierrez
- Ahmad HalimaAHAhmad Halima
- Mohamed MostafaMMMohamed Mostafa
- Yasser GhoneimYGYasser Ghoneim
- Mostafa AbdraboMAMostafa Abdrabo
- Moaz RashadMRMoaz Rashad
- Suad HannawiSHSuad Hannawi
- Yuan LiuYLYuan Liu
- Zenaida MojaresZMZenaida Mojares
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 13 (4) , 315-328
Abstract
Lim RJ, et al. Clin Exp Vaccine Res. 2024 Oct;13(4):315-328. https://doi.org/10.7774/cevr.2024.13.4.315Keywords
Funding Information
- YS Biopharma Co. Ltd
This publication has 35 references indexed in Scilit:
- Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-upeClinicalMedicine, 2022
- An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccinesJournal of Clinical Laboratory Analysis, 2022
- Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectivesClinical Epidemiology and Global Health, 2021
- Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measuresClinical & Translational Immunology, 2021
- An overview of current COVID-19 vaccine platformsComputational and Structural Biotechnology Journal, 2021
- Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patientsAntiviral Research, 2020
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell, 2020
- TLR Ligand–Peptide Conjugate Vaccines2012
- PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoVVirologica Sinica, 2011
- Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systemsJournal of Controlled Release, 2010